9 lugl 2018 anni - FDA hosted a public meeting on Patient-Focused
Drug Development for chronic pain to hearing
patients’ perspectives on chronic pain, views on
treatment approaches, and challenges or barriers
to accessing treatments for chronic pain.
Aggiunto al nastro di tempo:
Opioids and the FDA
Data:
